The Julian C. Gomez Law Firm, PLLC

The Julian C. Gomez Law Firm, PLLC

The Julian C. Gomez Law Firm, PLLC handles automotive, pharmaceutical, and other product centered and negligence cases.

FDA Warns That Type 2 Diabetes Medicines Called SGLT2 Inhibitors Such As Invokana May Result Ketoacidosis and Hospitalization

The Federal Drug Administration (FDA) is warning that the class of Type 2 Diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors, which includes Invokana, Invokamet, Farxiga, Xigduo XR, Jardiance, and Glyxambi, may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids and may require hospitalizations. Twenty cases have been reported from March 2013 to June 6, 2014.

If you, a family member, or friend have taken Invokana or any of the other SGLT2 Inhibitors, you/they may have a claim. Please contact The Julian C. Gomez Law Firm. We may be able to help.